Citigroup’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Citigroup’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,729,185	Closed	-$279M	–	7820
2014 Q4	$279M	Buy	2,729,185 +504,163	+23%	+$48.4M	0.25%	46
2014 Q3	$192M	Buy	2,225,022 +686,536	+45%	+$60.8M	0.17%	86
2014 Q2	$139M	Buy	1,538,486 +1,273,547	+481%	+$95.3M	0.13%	131
2014 Q1	$19.5M	Sell	264,939 -98,085	-27%	-$6.84M	0.02%	734
2013 Q4	$24.7M	Buy	363,024 +2,519	+0.7%	+$164K	0.02%	666
2013 Q3	$22M	Sell	360,505 -192,248	-35%	-$11.7M	0.02%	695
2013 Q2	$30.8M	Buy	+552,753	New	+$32M	0.03%	488

Citigroup's COV Position: Q1 2015 in Review

Citigroup sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,729,185 shares — an estimated $279M sold.

Citigroup first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $279M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

Citigroup reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
Citigroup sold 2,729,185 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $279M.
Citigroup first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
Citigroup's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $279M in Q4 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.